Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Care Delivery: New guidelines on chronic coronary disease | AI spots heart defects missed by the human eye
Wednesday, August 23, 2023
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Editor's Choice: Care Delivery

New U.S. guidelines on chronic coronary disease rethink use of beta-blockers, other medications

The updated recommendations from the American College of Cardiology and American Heart Association cover a variety of topics, including patient communication, follow-up imaging, nutritional supplements and more. 

READ MORE >
durbin-ama-opioid. The American College of Cardiology (ACC) and American Heart Association (AHA) have published new guidelines focused on the diagnosis, treatment and management of patients with chronic coronary disease (CCD).
Share on Twitter Share on Facebook Share on Linkedin

New U.S. guidelines on chronic coronary disease rethink use of beta-blockers, other medications

Share on Twitter Share on Facebook Share on Linkedin
durbin-ama-opioid. The American College of Cardiology (ACC) and American Heart Association (AHA) have published new guidelines focused on the diagnosis, treatment and management of patients with chronic coronary disease (CCD).
The updated recommendations from the American College of Cardiology and American Heart Association cover a variety of topics, including patient communication, follow-up imaging, nutritional supplements and more. 
READ MORE >

Missed opportunities: Many high-risk patients still not taking aspirin to prevent CVD

Aspirin is known to be an effective, affordable way to prevent cardiovascular disease.

READ MORE >
pills-384846_960_720.jpg
Share on Twitter Share on Facebook Share on Linkedin

Missed opportunities: Many high-risk patients still not taking aspirin to prevent CVD

Share on Twitter Share on Facebook Share on Linkedin
pills-384846_960_720.jpg
Aspirin is known to be an effective, affordable way to prevent cardiovascular disease.
READ MORE >

AI model for HCM, the first of its kind, gains FDA approval

The new-look AI model was designed to automatically evaluate ECGs for signs of HCM and send alerts to the care team when necessary. 

READ MORE >
artificial intelligence robot evaluates healthcare data. Novo Nordisk announced a new collaboration with Valo Health, a healthcare technology company focused on using artificial intelligence (AI) technology to identify new drug treatments for cardiovascular disease (CVD).
Share on Twitter Share on Facebook Share on Linkedin

AI model for HCM, the first of its kind, gains FDA approval

Share on Twitter Share on Facebook Share on Linkedin
artificial intelligence robot evaluates healthcare data. Novo Nordisk announced a new collaboration with Valo Health, a healthcare technology company focused on using artificial intelligence (AI) technology to identify new drug treatments for cardiovascular disease (CVD).
The new-look AI model was designed to automatically evaluate ECGs for signs of HCM and send alerts to the care team when necessary. 
READ MORE >

AI spots critical heart defects missed by the human eye

“If we can deploy our model on a population-level ECG screening, we would be able to pick up many more of these patients before they have irreversible damage,” a cardiologist behind the new study explained. 

READ MORE >
artificial intelligence AI deep learning ChatGPT OpenAI Microsoft Google
Share on Twitter Share on Facebook Share on Linkedin

AI spots critical heart defects missed by the human eye

Share on Twitter Share on Facebook Share on Linkedin
artificial intelligence AI deep learning ChatGPT OpenAI Microsoft Google
“If we can deploy our model on a population-level ECG screening, we would be able to pick up many more of these patients before they have irreversible damage,” a cardiologist behind the new study explained. 
READ MORE >

Relaxed fasting instructions prior to TAVR, other heart procedures do not affect outcomes

Fasting before major operations has been common in healthcare for nearly 80 years, but that has started to change since the turn of the century. 

READ MORE >
fasting before tavr or ablation
Share on Twitter Share on Facebook Share on Linkedin

Relaxed fasting instructions prior to TAVR, other heart procedures do not affect outcomes

Share on Twitter Share on Facebook Share on Linkedin
fasting before tavr or ablation
Fasting before major operations has been common in healthcare for nearly 80 years, but that has started to change since the turn of the century. 
READ MORE >

Heart specialists receive nearly $30M to study PCI and CABG among underrepresented patient groups

Teams from the Icahn School of Medicine at Mount Sinai and Weill Cornell Medicine will collaborate on the research. 

READ MORE >
a patient talks with her doctor, both are women of color
Share on Twitter Share on Facebook Share on Linkedin

Heart specialists receive nearly $30M to study PCI and CABG among underrepresented patient groups

Share on Twitter Share on Facebook Share on Linkedin
a patient talks with her doctor, both are women of color
Teams from the Icahn School of Medicine at Mount Sinai and Weill Cornell Medicine will collaborate on the research. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup